Evaluating a non-invasive device for monitoring blood flow during surgery
Evaluation of Clinical Utility of Non-invasive Hemodynamic Monitoring Device (HemoVista™) in the Clinical Filed
This study is testing a new non-invasive device for monitoring blood flow during surgery to see if it works as well as the traditional method.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | Seoul National University Hospital Academic / other |
| Locations | 1 site (Seoul, Soul-t'ukpyolsi) |
| Trial ID | NCT05996965 on ClinicalTrials.gov |
What this trial studies
This study compares the effectiveness of a non-invasive hemodynamic monitoring device, HemoVista, with the traditional invasive monitoring method, FloTrac, in patients undergoing surgery under general anesthesia. Participants will have both devices attached to monitor their hemodynamic status simultaneously. The goal is to assess the accuracy and clinical utility of the non-invasive method in a surgical setting. This observational study will provide valuable data on the potential benefits of using non-invasive monitoring techniques in clinical practice.
Who should consider this trial
Good fit: Ideal candidates are adult patients aged 20 or older who are scheduled for surgeries requiring general anesthesia lasting more than two hours and need invasive hemodynamic monitoring.
Not a fit: Patients with issues at the site where the HemoVista device is attached may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to safer surgical procedures by providing a reliable non-invasive method for monitoring hemodynamic status.
How similar studies have performed: While non-invasive monitoring techniques have been explored, this specific comparison with HemoVista and FloTrac is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients aged 20 or older who undergo surgery under general anesthesia for more than two hours * invasive close hemodynamic monitoring with FloTrac is needed Exclusion Criteria: * problems in site where HemoVista is attached
Where this trial is running
Seoul, Soul-t'ukpyolsi
- Hee-Soo Kim — Seoul, Soul-t'ukpyolsi, Korea, Republic of (Recruiting)
Study contacts
- Study coordinator: Hee-Soo Kim
- Email: dami0605@snu.ac.kr
- Phone: +82220723659
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.